Literature DB >> 24403562

Dantrolene: from better bacon to a treatment for ventricular fibrillation.

Dan M Roden1, Björn C Knollmann.   

Abstract

Entities:  

Keywords:  Editorials; dantrolene; excitation contraction coupling; ryanodine receptor calcium release channel; ventricular fibrillation

Mesh：

Substances：

Year:  2014        PMID： 24403562      PMCID： PMC3959791          DOI： 10.1161/CIRCULATIONAHA.113.007657

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  28 in total

1.  Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor?

Authors:  Andrew R Marks; Steven Reiken; Steven O Marx
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

2.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

3.  Dantrolene improves survival after ventricular fibrillation by mitigating impaired calcium handling in animal models.

Authors:  Nima Zamiri; Stéphane Massé; Andrew Ramadeen; Marjan Kusha; Xudong Hu; Mohammed Ali Azam; Jie Liu; Patrick F H Lai; Edward J Vigmond; Patrick M Boyle; Elham Behradfar; Abdul Al-Hesayen; Menashe B Waxman; Peter Backx; Paul Dorian; Kumaraswamy Nanthakumar
Journal:  Circulation       Date:  2014-01-08       Impact factor: 29.690

4.  Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.

Authors:  S G Priori; C Napolitano; N Tiso; M Memmi; G Vignati; R Bloise; V Sorrentino; G A Danieli
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

5.  Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium.

Authors:  K O Ellis; S H Bryant
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Dantrolene prevents arrhythmogenic Ca2+ release in heart failure.

Authors:  Joshua T Maxwell; Timothy L Domeier; Lothar A Blatter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-16       Impact factor: 4.733

7.  Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.

Authors:  Qiang Zhou; Jianmin Xiao; Dawei Jiang; Ruiwu Wang; Kannan Vembaiyan; Aixia Wang; Chris D Smith; Cuihong Xie; Wenqian Chen; Jingqun Zhang; Xixi Tian; Peter P Jones; Xiaowei Zhong; Ang Guo; Haiyan Chen; Lin Zhang; Weizhong Zhu; Dongmei Yang; Xiaodong Li; Ju Chen; Anne M Gillis; Henry J Duff; Heping Cheng; Arthur M Feldman; Long-Sheng Song; Michael Fill; Thomas G Back; S R Wayne Chen
Journal:  Nat Med       Date:  2011-07-10       Impact factor: 53.440

8.  A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.

Authors:  H Lahat; E Pras; T Olender; N Avidan; E Ben-Asher; O Man; E Levy-Nissenbaum; A Khoury; A Lorber; B Goldman; D Lancet; M Eldar
Journal:  Am J Hum Genet       Date:  2001-10-25       Impact factor: 11.025

Review 9.  Ryanodine receptor phosphorylation, calcium/calmodulin-dependent protein kinase II, and life-threatening ventricular arrhythmias.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Trends Cardiovasc Med       Date:  2011-02       Impact factor: 6.677

10.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Christian B Jung; Alessandra Moretti; Michael Mederos y Schnitzler; Laura Iop; Ursula Storch; Milena Bellin; Tatjana Dorn; Sandra Ruppenthal; Sarah Pfeiffer; Alexander Goedel; Ralf J Dirschinger; Melchior Seyfarth; Jason T Lam; Daniel Sinnecker; Thomas Gudermann; Peter Lipp; Karl-Ludwig Laugwitz
Journal:  EMBO Mol Med       Date:  2012-01-25       Impact factor: 12.137
View more
  4 in total

Review 1.  Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases.

Authors:  Norbert Szentandrássy; Zsuzsanna É Magyar; Judit Hevesi; Tamás Bányász; Péter P Nánási; János Almássy
Journal:  Int J Mol Sci       Date:  2022-04-18       Impact factor: 6.208

Review 2.  Emerging Antiarrhythmic Drugs for Atrial Fibrillation.

Authors:  Arnela Saljic; Jordi Heijman; Dobromir Dobrev
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

3.  Dantrolene versus amiodarone for cardiopulmonary resuscitation: a randomized, double-blinded experimental study.

Authors:  Thomas Wiesmann; Dennik Freitag; Wolfgang Dersch; Daphne Eschbach; Marc Irqsusi; Thorsten Steinfeldt; Hinnerk Wulf; Carsten Feldmann
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

4.  Atrial Infarction-Induced Spontaneous Focal Discharges and Atrial Fibrillation in Sheep: Role of Dantrolene-Sensitive Aberrant Ryanodine Receptor Calcium Release.

Authors:  Uma Mahesh R Avula; Jonathan J Hernandez; Masatoshi Yamazaki; Carmen R Valdivia; Antony Chu; Alvaro Rojas-Pena; Kuljeet Kaur; Roberto Ramos-Mondragón; Justus M Anumonwo; Stanley Nattel; Héctor H Valdivia; Jérôme Kalifa
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.